⌘K

Login Start Free

Home/Filings/4/0001213900-24-051336

4//SEC Filing

Reznick Yehuda 4

Accession 0001213900-24-051336

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 5:15 PM ET

Size

5.0 KB

Accession

0001213900-24-051336

Insider Transaction Report

Form 4

Period: 2024-06-06

ORAMED PHARMACEUTICALS INC.ORMP

Director

Transactions

Award
Common Stock
2024-06-06+760→ 30,560 total

Footnotes (1)

[F1]Represents a grant of 760 Restricted Stock Units ("RSUs") that will vest in two equal installments on October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0002015556

Filing Metadata

Form type: 4
Filed: Jun 9, 8:00 PM ET
Accepted: Jun 10, 5:15 PM ET
Size: 5.0 KB

View on SEC.gov